EDGAR Filing Documents for 0001532199-14-000006

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001532199-14-000006

Filing Date

2014-09-08

Accepted

2014-09-08 13:42:48

Documents

Period of Report

2014-09-04

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4
1	PRIMARY DOCUMENT	primary_doc.xml	4	5277
	Complete submission text file	0001532199-14-000006.txt		6868

Mailing Address 30 ROCKEFELLER PLAZA SUITE 4250 NEW YORK NY 10112

Business Address 30 ROCKEFELLER PLAZA SUITE 4250 NEW YORK NY 10112 212-433-1375

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-55046 | Film No.: 141090257

Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025

Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 510-521-3390

Asterias Biotherapeutics, Inc. (Issuer) CIK: 0001572552 (see all company filings)

IRS No.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)